1) Hepatic bone disease
肝性骨病
1.
To investigate the relationship between urine crosslaps,urine Ca 2+/Cr and hepatic bone disease(HBD),levels of urine crosslaps and urine Ca 2+/Cr were detected in 61 male cirrhosis and 30 age-matched healthy controls.
提示尿Ca2 + /Cr不能作为肝硬化骨吸收指标 ,而尿Crosslaps变化对肝性骨病的诊断有一定意
2) hepatic encephalopathy
肝性脑病
1.
The influence of 5-hydroxytryptamine on rat with hepatic encephalopathy.;
五羟色胺对大鼠肝性脑病影响的研究
2.
EEG,CT and MRI findings in hepatic encephalopathy;
肝性脑病患者的EEG、CT和MRI研究
3.
Research on syndrome and treatment of TCM in hepatic encephalopathy;
肝性脑病的中医证治研究
3) chronic liver disease
慢性肝病
1.
Changes of serum argininosuccinate lyase levels in patients with chronic liver diseases;
慢性肝病患者血清精氨[基]琥珀酸裂合酶的变化
2.
A survey of influencing factors of chronic liver disease patients with sleep disorder;
慢性肝病病人睡眠障碍的影响因素调查
3.
A study on sleeping state of patients with chronic liver disease;
慢性肝病病人的睡眠状况研究
4) Chronic liver diseases
慢性肝病
1.
Objective To study the correlation between serum level of PCⅢ and the degree of liver fibrosis in patients with chronic liver diseases.
目的:探讨慢性肝病患者血清Ⅲ型前胶原(PCⅢ)水平与肝纤维化病变程度的相关性及进程的分级判定作用。
2.
The content of serum HA and SCG is determined by RIA in 150 patients of chronic liver diseases.
结果表明 :慢性肝病患者血清中 HA和 SCG的含量显著高于对照组 ( P<0 。
3.
Objective:To reevaluate the blood endotoxin concentration in patients with chronic liver diseases by means of dynamic turbidimetric analysis.
目的:采用动态浊度法对慢性肝病患者血、腹水中内毒素水平进行再评估。
5) Chronic hepatopathy
慢性肝病
1.
Application of protein chip technology for investigation of changes of various serum cytokines in patients with chronic hepatopathy;
应用蛋白芯片技术观察慢性肝病患者血清细胞因子的变化规律
2.
Methods 18 normal rats and 36 chronic hepatopathy rats divided into:①normal ofloxacin protective group; ②normal PGE2 immuno-intervention group;③hepatopathy ofloxacin protective group;④hepatopathy PGE2 immuno-intervention combined ofloxacin protective group;⑤hepatopathy negative group; ⑥ hepa.
方法取18只正常大鼠和36只慢性肝病大鼠,随机分成:①正常氧氟沙星治疗组;②正常PGE2免疫干预与氧氟沙星联合保护组;③肝病氧氟沙星等药物治疗组;④肝病PGE2免疫干预与氧氟沙星等药物联合保护组;⑤肝病大鼠阴性对照组;⑥肝病大鼠Vv攻击对照组(n=9)。
3.
Methods: Eighteen chronic hepatopathy rats which were prepared by carbon tetrachloride were divided into Vv attack group and control group to make multiple organ dysfunction hepatopathy rat models of Vv lethal infection (5.
方法：采用四氯化碳制备慢性肝病大鼠18只,分Vv攻击和肝病大鼠对照组(n=9),Vv致死性感染多器官损伤肝病大鼠模型(5。
6) chronic hepatic disease
慢性肝病
1.
Detection and significance of Insulin-like Growth Factor-Ⅰ in serum of patients with chronic hepatic diseases;
胰岛素样生长因子-Ⅰ在慢性肝病患者血清中的测定及意义
2.
Objective To study the effects of nurse-guided progressive relaxation training on improving the difficulty falling asleep in patients with chronic hepatic diseases.
目的观察护士引导下渐进性放松术改善慢性肝病患者睡眠障碍的效果。
3.
Objective:To investigate the changes of serum IL-6,IL-8,IL-10 and TNF-α levels in patients with chronic hepatic disease.
目的:探讨慢性肝病患者血清白细胞介素6(IL6)、白细胞介素8(IL8)、白细胞介素10(IL10)和肿瘤坏死因子(TNFα)在肝病发展过程中的含量变化及临床意义。
补充资料：肺性肥大性骨关节病
肺性肥大性骨关节病
趾
系胸部或其他系统慢性疾患使组织缺氧和局部血循环量增加而继发的骨关节改变。起病于中年人，男多于女。四肢长管骨痛、压痛、增粗。关节红肿、温度升高。四肢末梢循环异常，患肢下垂时疼痛增加。可伴有杵状指(趾)畸形。X线摄片可见骨干骨膜下新骨形成，从远端向近端蔓延而逐渐减弱，呈花边样或葱皮样。预后与原发病关系密切，原发病治愈后，本病可很快减轻或消失。骨关节疼痛剧烈者，可给消炎止痛药或皮质激素。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条